A. Soubieres

Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease.

A. Poullis, A. Soubieres, 2016, World journal of gastrointestinal pharmacology and therapeutics.

Colorectal cancer detection by biomarker quantification in noninvasively collected colorectal mucus: preliminary comparison of 24 protein biomarkers.

A. Poullis, A. Loktionov, Jai Mathur, 2019, European journal of gastroenterology & hepatology.

Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases

A. Poullis, A. Soubieres, 2016, Inflammatory bowel diseases.

Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study

T. Hallett, M. Vollmer, N. Ferguson, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Report 17: Clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study

T. Hallett, M. Vollmer, N. Ferguson, 2020 .

In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19

M. Thursz, B. Mullish, M. Lemoine, 2020, PloS one.

Burden of irritable bowel syndrome in an increasingly cost-aware National Health Service

A. Poullis, J. Wilkins, P. Wilson, 2015, Frontline Gastroenterology.

Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications

A. Poullis, A. Loktionov, Jai Mathur, 2020, British Journal of Cancer.

Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: a retrospective cohort study

S. Preston, B. Hayee, D. Graham, 2020, Frontline Gastroenterology.